Printable and Free-Standing Silicon-Based Anode for Current Collector-Free Lithium-Ion Batteries.

The evolution of Li-ion rechargeable batteries has driven a demand for systems exceeding the energy density and shape diversity of conventional lithium-ion batteries. Silicon (Si)-based materials, suitable for high-energy-density applications, have been restricted in practical use due to their inherent structural instability and poor conductivities upon electrochemical cycling. Here, we propose a fully printable and free-standing anode, composed of hollow SiOx/C (H-SiOx/C) composite material and an MXene conductive binder, exhibiting high specific capacity, structural reliability, and superior ionic conductivity without any current collector. The hollow structure of H-SiOx/C accommodates volume changes during cycling, while the MXene binder forms a three-dimensional interconnected conducting structure for maintaining the structural integrity of electrodes without a current collector. Furthermore, the printability and free-standing nature of the H-SiOx/C/MXene anode are validated in both coin-type full cell and heart-shaped pouch cell configurations through a straightforward stencil printing technique. This work establishes a foundation for advanced Si-based anodes, enhancing performance and design flexibility and potentially contributing to practical printable battery systems.

Enhanced Coloration Time of Electrochromic Device Using Integrated WO3@PEO Electrodes for Wearable Devices.

Electrochromic technologies that exhibit low power consumption have been spotlighted recently. In particular, with the recent increase in demand for paper-like panel displays, faster coloration time has been focused on in researching electrochromic devices. Tungsten trioxide (WO3) has been widely used as an electrochromic material that exhibits excellent electrochromic performance with high thermal and mechanical stability. However, in a solid film-type WO3 layer, the coloration time was long due to its limited surface area and long diffusion paths of lithium ions (Li-ions). In this study, we attempted to fabricate a fibrous structure of WO3@poly(ethylene oxide) (PEO) composites through electrospinning. The fibrous and porous layer showed a faster coloration time due to a short Li-ion diffusion path. Additionally, PEO in fibers supports Li-ions being quickly transported into the WO3 particles through their high ionic conductivity. The optimized WO3@PEO fibrous structure showed 61.3 cm2/C of high coloration efficiency, 1.6s fast coloration time, and good cycle stability. Lastly, the electrochromic device was successfully fabricated on fabric using gel electrolytes and a conductive knitted fabric as a substrate and showed a comparable color change through a voltage change from -2.5 V to 1.5 V.

Enhancing Stiffness and Oil Resistance of Fluorosilicone Rubber Composites through Untreated Cellulose Reinforcement.

Fluorosilicone rubber, essential in automotive and aerospace owing to its excellent chemical resistance, plays a pivotal role in sealing technology, addressing the industry's evolving demands. This study explores the preparation and properties of fibrillated cellulose-reinforced fluorosilicone rubber composites to enhance their stiffness and oil resistance. Fibrillated cellulose sourced as a wet cake and subjected to processing and modification is incorporated into a fluorosilicone rubber matrix. The resulting composites are analysed by tensile and compression tests, along with compressive stress-relaxation testing in air and in an oil-immersed environment. The findings demonstrate significant improvements in the mechanical properties, including an increased Young's modulus and elongation at break, whereas the tensile strength remained uncompromised throughout the testing procedures. Morphological analysis of the fracture surfaces revealed a remarkable interfacial affinity between the fibrillated cellulose and rubber matrix, which was attributed in part to the modified fatty acids and inorganic nanoparticles. The presence of fibrillated cellulose enhanced the stress-relaxation characteristics under oil-immersion conditions. These results contribute to the domain of advanced elastomer materials, with potential for applications requiring enhanced mechanical properties and superior oil resistance.

Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment.

Purpose: Current understanding of COVID-19 disease progression suggests a major role for the "cytokine storm" as an important contributor to COVID-19 mortality. To prevent an exaggerated immune response and improve COVID-19 patient endpoints, anti-inflammatory therapeutics have been proposed as clinically useful in severe patients with COVID-19. The purpose of this study was to propose a clinical trial design for the development of anti-inflammatory agents for the treatment of COVID-19, taking into account the physiological and immunological process of COVID-19 and the treatment mechanism of anti-inflammatory agents. Methods: We reviewed and analyzed the guidelines for the development of COVID-19 treatments and the treatment of COVID-19 by regulatory agencies and previously conducted clinical trials on anti-inflammatory drugs for COVID-19. Finally, after discussing with an advisory group, a synopsis was presented for an example protocol for a COVID-19 anti-inflammatory agent phase 2 or 3 study that considers the drug mechanism and the disease progression of COVID-19. Results: A randomized, placebo-controlled, double-blind parallel-group design was suggested as a phase 2 or 3 trial design for developing an anti-inflammatory agent as a COVID-19 treatment. A key item of the example protocol specific to anti-inflammatory agents was the inclusion and exclusion criteria, taking into account the immunosuppressive effects of the drug, clinical time course of COVID-19 disease, and treatment guidelines for COVID-19. Time to recovery is the primary endpoint associated with clinical efficacy and is generally well accepted by many experts. Conclusion: Through this suggested phase 2 or 3 study design of an anti-inflammatory drug for COVID-19, we provide a basis for a study design that can be utilized in clinical development by pharmaceutical companies which are developing a potential anti-inflammatory agent for COVID-19.

Evaluation of food effects on the pharmacokinetics of Pelargonium sidoides and Coptis with each bioactive compound berberine and epicatechin after a single oral dose of an expectorant and antitussive agent UI026 in healthy subjects.

UI026 is an expectorant and antitussive agent which is a new combination of Pelargonium sidoides extract and Coptis extract. The bioactive compounds of Pelargonium sidoides and Coptis extracts were identified as epicatechin and berberine, respectively. This study evaluated the effect of food on the pharmacokinetics (PKs) and safety of UI026. A randomized, open-label, single-dose, 2-treatment, parallel study in 12 healthy male subjects was performed. Subjects received a single oral dose of UI026 (27 mL of syrup) under a fed or fasted condition according to their randomly assigned treatment. Blood samples for the PK analysis were obtained up to 24 hours post-dose for berberine and 12 hours post-dose for epicatechin. The PK parameters were calculated by non-compartmental analysis. In the fed condition, the mean maximum plasma concentration (Cmax) and mean area under the plasma concentration-time curve from time zero to the last observed time point (AUClast) for berberine were approximately 33% and 67% lower, respectively, compared with the fasted condition, both showing statistically significant difference. For epicatechin, the mean Cmax and mean AUClast were about 29% and 45% lower, respectively, compared to the fasting condition, neither of which showed a statistically significant difference. There were no drug-related adverse events. This finding suggests that food affects the systemic exposure and bioavailability of berberine and epicatechin. Trial Registration: Clinical Research Information Service Identifier: KCT0003451.